{"id":"https://openalex.org/W4391944149","doi":"https://doi.org/10.2217/frd-2023-0001","title":"Study design of BI 1015550 for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: a plain language summary","display_name":"Study design of BI 1015550 for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: a plain language summary","publication_year":2024,"publication_date":"2024-02-19","ids":{"openalex":"https://openalex.org/W4391944149","doi":"https://doi.org/10.2217/frd-2023-0001"},"language":"en","primary_location":{"id":"doi:10.2217/frd-2023-0001","doi":"https://doi.org/10.2217/frd-2023-0001","is_oa":true,"landing_page_url":"https://doi.org/10.2217/frd-2023-0001","pdf_url":"https://www.tandfonline.com/doi/pdf/10.2217/frd-2023-0001?needAccess=true","source":{"id":"https://openalex.org/S4210192452","display_name":"Future Rare Diseases","issn_l":"2399-5270","issn":["2399-5270","2399-5262"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Rare Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.tandfonline.com/doi/pdf/10.2217/frd-2023-0001?needAccess=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058325633","display_name":"Toby M. Maher","orcid":"https://orcid.org/0000-0001-7192-9149","observed_orcids":["https://orcid.org/0000-0001-7192-9149"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Toby M Maher","raw_affiliation_strings":["Keck Medicine of USC, Los Angeles, CA, USA","National Heart & Lung, Institute, Imperial College London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Keck Medicine of USC, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I1174212"]},{"raw_affiliation_string":"National Heart & Lung, Institute, Imperial College London, London, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053644656","display_name":"Arata Azuma","orcid":"https://orcid.org/0000-0003-0506-9966","observed_orcids":["https://orcid.org/0000-0003-0506-9966"]},"institutions":[{"id":"https://openalex.org/I4405256555","display_name":"Mimihara General Hospital","ror":"https://ror.org/049y5v215","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405256555"]},{"id":"https://openalex.org/I80188885","display_name":"Nippon Medical School","ror":"https://ror.org/00krab219","country_code":"JP","type":"education","lineage":["https://openalex.org/I80188885"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Arata Azuma","raw_affiliation_strings":["Pulmonary Medicine & Clinical Research Center, Mihara General Hospital, Saitama Japan","Pulmonary Medicine & Oncology, Nippon Medical School, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pulmonary Medicine & Clinical Research Center, Mihara General Hospital, Saitama Japan","institution_ids":["https://openalex.org/I4405256555"]},{"raw_affiliation_string":"Pulmonary Medicine & Oncology, Nippon Medical School, Tokyo, Japan","institution_ids":["https://openalex.org/I80188885"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014703126","display_name":"Vincent Cottin","orcid":"https://orcid.org/0000-0002-5591-0955","observed_orcids":["https://orcid.org/0000-0002-5591-0955"]},"institutions":[{"id":"https://openalex.org/I100532134","display_name":"Lyon 1 Universit\u00e9","ror":"https://ror.org/029brtt94","country_code":"FR","type":"education","lineage":["https://openalex.org/I100532134","https://openalex.org/I203339264"]},{"id":"https://openalex.org/I4210088668","display_name":"Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement","ror":"https://ror.org/003vg9w96","country_code":"FR","type":"government","lineage":["https://openalex.org/I4210088668"]},{"id":"https://openalex.org/I4210100596","display_name":"Hospices Civils de Lyon","ror":"https://ror.org/01502ca60","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596"]},{"id":"https://openalex.org/I4210136143","display_name":"H\u00f4pital Louis Pradel","ror":"https://ror.org/0396v4y86","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596","https://openalex.org/I4210136143"]},{"id":"https://openalex.org/I4387155109","display_name":"Infections Virales et Pathologie Compar\u00e9e","ror":"https://ror.org/015a85k79","country_code":"FR","type":"facility","lineage":["https://openalex.org/I100532134","https://openalex.org/I159885104","https://openalex.org/I203339264","https://openalex.org/I2746051580","https://openalex.org/I4210088668","https://openalex.org/I4387155109"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Vincent Cottin","raw_affiliation_strings":["H\u00f4pital Louis Pradel, Centre Coordonnateur National de r\u00e9f\u00e9rence des Maladies Pulmonaires Rares, Hospices Civils de Lyon, UMR754, INRAE, Universit\u00e9 Claude Bernard Lyon 1, member of ERN-LUNG, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital Louis Pradel, Centre Coordonnateur National de r\u00e9f\u00e9rence des Maladies Pulmonaires Rares, Hospices Civils de Lyon, UMR754, INRAE, Universit\u00e9 Claude Bernard Lyon 1, member of ERN-LUNG, Lyon, France","institution_ids":["https://openalex.org/I100532134","https://openalex.org/I4210088668","https://openalex.org/I4210100596","https://openalex.org/I4210136143","https://openalex.org/I4387155109"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024950256","display_name":"Shervin Assassi","orcid":"https://orcid.org/0000-0002-8059-9978","observed_orcids":["https://orcid.org/0000-0002-8059-9978"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shervin Assassi","raw_affiliation_strings":["Division of Rheumatology, McGovern Medical School, University of Texas, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Rheumatology, McGovern Medical School, University of Texas, Houston, TX, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005002226","display_name":"Anna\u2010Maria Hoffmann\u2010Vold","orcid":"https://orcid.org/0000-0001-6467-7422","observed_orcids":["https://orcid.org/0000-0001-6467-7422"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Anna-Maria Hoffmann-Vold","raw_affiliation_strings":["Department of Rheumatology, Oslo University Hospital, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rheumatology, Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107946132","display_name":"Michael Kreuter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094062","display_name":"University Medical Center of the Johannes Gutenberg University Mainz","ror":"https://ror.org/00q1fsf04","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094062"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Michael Kreuter","raw_affiliation_strings":["Department of Pulmonary, Critical Care & Sleep Medicine, Marienhaus Clinic Mainz, Mainz, Germany","Mainz Center for Pulmonary Medicine, Department of Pneumology, Mainz University Medical Center, Mainz, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pulmonary, Critical Care & Sleep Medicine, Marienhaus Clinic Mainz, Mainz, Germany","institution_ids":[]},{"raw_affiliation_string":"Mainz Center for Pulmonary Medicine, Department of Pneumology, Mainz University Medical Center, Mainz, Germany","institution_ids":["https://openalex.org/I4210094062"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100767595","display_name":"Fernando J. Mart\u00ednez","orcid":"https://orcid.org/0000-0002-2412-3182","observed_orcids":["https://orcid.org/0000-0002-2412-3182","https://orcid.org/0000-0003-4957-8869","https://orcid.org/0000-0001-8298-2703"]},"institutions":[{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fernando J Martinez","raw_affiliation_strings":["Department of Medicine, Cornell University, New York City, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Cornell University, New York City, NY, USA","institution_ids":["https://openalex.org/I205783295"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009091055","display_name":"Justin M. Oldham","orcid":"https://orcid.org/0000-0003-4957-8869","observed_orcids":["https://orcid.org/0000-0003-4957-8869"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Justin M Oldham","raw_affiliation_strings":["University of Michigan, Pulmonary & Critical Care Medicine, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan, Pulmonary & Critical Care Medicine, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315","https://openalex.org/I4210114445"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060426000","display_name":"Claudia Valenzuela","orcid":"https://orcid.org/0000-0002-0856-6290","observed_orcids":["https://orcid.org/0000-0002-0856-6290"]},"institutions":[{"id":"https://openalex.org/I4210130498","display_name":"Hospital Universitario de La Princesa","ror":"https://ror.org/03cg5md32","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210130498","https://openalex.org/I4210139293"]},{"id":"https://openalex.org/I63634437","display_name":"Universidad Aut\u00f3noma de Madrid","ror":"https://ror.org/01cby8j38","country_code":"ES","type":"education","lineage":["https://openalex.org/I63634437"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Claudia Valenzuela","raw_affiliation_strings":["ILD Unit, Pulmonology Department, Hospital Universitario de la Princesa, Universidad Autonomade Madrid, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ILD Unit, Pulmonology Department, Hospital Universitario de la Princesa, Universidad Autonomade Madrid, Madrid, Spain","institution_ids":["https://openalex.org/I4210130498","https://openalex.org/I63634437"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038846995","display_name":"Marlies S Wijsenbeek","orcid":"https://orcid.org/0000-0002-4527-6962","observed_orcids":["https://orcid.org/0000-0002-4527-6962"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Marlies S Wijsenbeek","raw_affiliation_strings":["Centre for Interstitial Lung Diseases & Sarcoidosis, Department of Respiratory Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Interstitial Lung Diseases & Sarcoidosis, Department of Respiratory Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100330520","display_name":"Yi Liu","orcid":"https://orcid.org/0000-0002-3744-0590","observed_orcids":["https://orcid.org/0000-0002-3744-0590"]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yi Liu","raw_affiliation_strings":["Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009301505","display_name":"Daniel Wachtlin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Daniel Wachtlin","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091576695","display_name":"Susanne Stowasser","orcid":"https://orcid.org/0009-0008-6013-0225","observed_orcids":["https://orcid.org/0009-0008-6013-0225"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Susanne Stowasser","raw_affiliation_strings":["TA Inflammation Med, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TA Inflammation Med, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075075363","display_name":"Donald F. Zoz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Donald F Zoz","raw_affiliation_strings":["Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019441565","display_name":"Luca Richeldi","orcid":"https://orcid.org/0000-0001-8594-1448","observed_orcids":["https://orcid.org/0000-0001-8594-1448"]},"institutions":[{"id":"https://openalex.org/I103320735","display_name":"Universit\u00e0 Cattolica del Sacro Cuore","ror":"https://ror.org/03h7r5v07","country_code":"IT","type":"education","lineage":["https://openalex.org/I103320735"]},{"id":"https://openalex.org/I2802557943","display_name":"Agostino Gemelli University Polyclinic","ror":"https://ror.org/00rg70c39","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I2802557943"]},{"id":"https://openalex.org/I4210153126","display_name":"Istituti di Ricovero e Cura a Carattere Scientifico","ror":"https://ror.org/04tfzc498","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Luca Richeldi","raw_affiliation_strings":["Unit\u00e0 Operativa Complessa di Pneumologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit\u00e0 Operativa Complessa di Pneumologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy","institution_ids":["https://openalex.org/I103320735","https://openalex.org/I2802557943","https://openalex.org/I4210153126"]}]}],"institutions":[],"countries_distinct_count":9,"institutions_distinct_count":22,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.03561848,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"4","issue":"1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11026","display_name":"Occupational and environmental lung diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/idiopathic-pulmonary-fibrosis","display_name":"idiopathic pulmonary fibrosis","score":0.9879999756813049},{"id":"https://openalex.org/keywords/progressive-pulmonary-fibrosis","display_name":"progressive pulmonary fibrosis","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pulmonary-fibrosis","display_name":"pulmonary fibrosis","score":0.7329999804496765},{"id":"https://openalex.org/keywords/antifibrotic-therapy","display_name":"antifibrotic therapy","score":0.7559999823570251},{"id":"https://openalex.org/keywords/lung-scarring","display_name":"lung scarring","score":0.8550000190734863},{"id":"https://openalex.org/keywords/lung-function-decline","display_name":"lung function decline","score":0.9380000233650208},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.6570000052452087},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6769999861717224}],"concepts":[{"id":"https://openalex.org/C2781244666","wikidata":"https://www.wikidata.org/wiki/Q32446","display_name":"Pulmonary fibrosis","level":3,"score":0.7341974973678589},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7030258774757385},{"id":"https://openalex.org/C2778341716","wikidata":"https://www.wikidata.org/wiki/Q2290446","display_name":"Idiopathic pulmonary fibrosis","level":3,"score":0.5901498794555664},{"id":"https://openalex.org/C2780559512","wikidata":"https://www.wikidata.org/wiki/Q605709","display_name":"Fibrosis","level":2,"score":0.3712626099586487},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.35057467222213745},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3201974034309387},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.238002210855484}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2217/frd-2023-0001","doi":"https://doi.org/10.2217/frd-2023-0001","is_oa":true,"landing_page_url":"https://doi.org/10.2217/frd-2023-0001","pdf_url":"https://www.tandfonline.com/doi/pdf/10.2217/frd-2023-0001?needAccess=true","source":{"id":"https://openalex.org/S4210192452","display_name":"Future Rare Diseases","issn_l":"2399-5270","issn":["2399-5270","2399-5262"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Rare Diseases","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.2217/frd-2023-0001","doi":"https://doi.org/10.2217/frd-2023-0001","is_oa":true,"landing_page_url":"https://doi.org/10.2217/frd-2023-0001","pdf_url":"https://www.tandfonline.com/doi/pdf/10.2217/frd-2023-0001?needAccess=true","source":{"id":"https://openalex.org/S4210192452","display_name":"Future Rare Diseases","issn_l":"2399-5270","issn":["2399-5270","2399-5262"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Rare Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"},{"id":"https://openalex.org/F4320309555","display_name":"United Therapeutics Corporation","ror":"https://ror.org/03wgxjb31"},{"id":"https://openalex.org/F4320310420","display_name":"CSL Behring","ror":"https://ror.org/01jxhxv92"},{"id":"https://openalex.org/F4320315424","display_name":"aTyr","ror":"https://ror.org/05edt5833"},{"id":"https://openalex.org/F4320317585","display_name":"Galecto","ror":"https://ror.org/01cjch873"},{"id":"https://openalex.org/F4320318431","display_name":"Veracyte","ror":"https://ror.org/02t11pf93"},{"id":"https://openalex.org/F4320319146","display_name":"Horizon Therapeutics","ror":null},{"id":"https://openalex.org/F4320321007","display_name":"ZonMw","ror":"https://ror.org/01yaj9a77"},{"id":"https://openalex.org/F4320323316","display_name":"Shionogi","ror":"https://ror.org/01v3bqg10"},{"id":"https://openalex.org/F4320328814","display_name":"Lung Foundation Netherlands","ror":"https://ror.org/04gmab760"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4391944149.pdf","grobid_xml":"https://content.openalex.org/works/W4391944149.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4327934586","https://openalex.org/W4379794858","https://openalex.org/W4311993112","https://openalex.org/W4386754132","https://openalex.org/W4386003218","https://openalex.org/W4408555362","https://openalex.org/W7123971357","https://openalex.org/W4416986538","https://openalex.org/W7123420496","https://openalex.org/W4401232194"],"abstract_inverted_index":{"What":[0],"is":[1,42,71,191,196,294,320],"this":[2],"summary":[3],"about?":[4],"Two":[5],"ongoing":[6],"clinical":[7,120],"studies":[8,18,272],"are":[9,19,125,184,219,225,273,290],"part":[10,57],"of":[11,66,79,115,177,182,277],"a":[12,26,43,72,112,197,305],"programme":[13],"called":[14],"FIBRONEER.":[15],"The":[16,55,228,270,292],"FIBRONEER":[17,215,271],"testing":[20],"the":[21,53,64,67,77,90,139,163,174,207,214,244,254,275,288],"drug":[22,190,200,246,256],"BI":[23,194,221,233,278,298],"1015550":[24,195,222,234,279,299],"as":[25,97],"treatment":[27],"for":[28,102],"people":[29,36,311],"with":[30,37,284,312],"idiopathic":[31],"pulmonary":[32,39],"fibrosis":[33,40],"(IPF)":[34],"and":[35,101,123,132,144,159,172,180,211,223,281,314,316],"progressive":[38],"(PPF).IPF":[41],"severe":[44],"lung":[45,68,80,117,268,308],"disease":[46,84],"where":[47,85],"scar":[48,86,134],"tissue":[49,87,135],"builds":[50,136],"up":[51,137],"in":[52,82,89,119,138,150,157,206,209,282,307,310],"lungs.":[54],"\u2018idiopathic\u2019":[56],"means":[58],"that":[59],"doctors":[60],"do":[61],"not":[62,237],"know":[63],"cause":[65],"scarring.":[69,269],"PPF":[70,124,183],"general":[73],"term":[74],"to":[75,110,148,155,162,168,187,203,232,247,249,265,295],"describe":[76],"worsening":[78,116],"scarring":[81,205],"any":[83,239,285],"forms":[88],"lungs,":[91,140],"both":[92,130],"from":[93],"known":[94],"causes":[95],"such":[96],"other":[98],"underlying":[99],"diseases":[100],"unknown":[103],"reasons.":[104],"While":[105],"IPF":[106,122,131,210,313],"can":[107,300],"be":[108,111],"considered":[109,127],"typical":[113],"form":[114],"scarring,":[118],"studies,":[121,216],"usually":[126],"separately.":[128],"In":[129,213],"PPF,":[133,315],"making":[141,165],"them":[142],"smaller":[143],"no":[145],"longer":[146],"able":[147],"take":[149,261],"oxygen":[151,161],"well.":[152],"This":[153],"leads":[154],"difficulty":[156],"breathing":[158],"getting":[160],"tissues,":[164],"it":[166,319],"difficult":[167],"perform":[169],"daily":[170],"activities":[171],"reducing":[173],"patient's":[175],"quality":[176],"life.The":[178],"symptoms":[179],"outcomes":[181],"often":[185],"similar":[186],"IPF.What":[188],"study":[189,199,245,255],"being":[192,201],"investigated?":[193],"new":[198],"developed":[202],"reduce":[204],"lungs":[208],"PPF.":[212],"some":[217],"participants":[218,289],"taking":[220,226],"others":[224],"placebo.":[227],"placebo":[229,248],"looks":[230],"identical":[231],"but":[235],"does":[236],"contain":[238],"medicine.":[240],"Researchers":[241],"will":[242],"compare":[243],"find":[250],"out":[251],"how":[252,317],"well":[253,318],"works.":[257],"Participants":[258],"may":[259],"also":[260],"another":[262],"approved":[263],"medicine":[264],"treat":[266],"their":[267],"investigating":[274],"effects":[276],"alone":[280],"combination":[283],"existing":[286],"medicines":[287],"taking.":[291],"goal":[293],"see":[296],"whether":[297],"slow":[301],"down":[302],"or":[303],"stop":[304],"decline":[306],"function":[309],"tolerated.Clinical":[321],"Trial":[322],"Registration:":[323],"NCT05321069":[324],"FIBRONEER-IPF,":[325],"NCT05321082":[326],"FIBRONEER-ILD":[327],"(ClinicalTrials.gov)":[328]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2024-02-20T00:00:00"}